ARTELO BIOSCIENCES, INC. Shareholders' Equity
ARTELO BIOSCIENCES, INC. (ARTL) had Shareholders' Equity of $5.00 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $5.00M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $6.67M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$1.27M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$633.00K.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $5.00M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $6.67M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | -$1.27M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | -$633.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$1.41M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $652.00K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $2.86M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $6.36M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $7.30M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $9.54M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $11.75M 8-K · filed 2026-03-17 | |
| 2023-09-30 | $14.58M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $16.27M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $17.64M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $19.40M 8-K · filed 2025-07-11 | |
| 2022-09-30 | $21.90M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $23.84M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $25.78M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $27.17M 10-K · filed 2024-03-25 | |
| 2021-11-30 | $28.29M 10-Q · filed 2022-01-12 | |
| 2021-09-30 | $11.48M 10-Q · filed 2022-11-08 | |
| 2021-08-31 | $12.04M 10-K · filed 2023-03-31 | |
| 2021-06-30 | $12.84M 10-Q · filed 2022-11-08 | |
| 2021-05-31 | $11.92M 10-Q · filed 2021-07-12 | |
| 2021-03-31 | $13.29M 10-Q · filed 2022-11-08 | |
| 2021-02-28 | $12.86M 10-Q · filed 2021-07-12 | |
| 2020-12-31 | $8.44M 10-Q · filed 2022-11-08 | |
| 2020-11-30 | $9.05M 10-Q · filed 2022-01-12 | $9.05M 10-Q · filed 2021-01-14 |
| 2020-08-31 | $3.88M 10-K · filed 2023-03-31 | $3.87M 10-K · filed 2020-11-04 |
| 2020-05-31 | $3.23M 10-Q · filed 2021-07-12 | |
| 2020-02-29 | $3.71M 10-Q · filed 2021-07-12 | |
| 2019-11-30 | $4.96M 10-Q · filed 2021-07-12 | |
| 2019-08-31 | $5.46M 10-KT · filed 2022-03-21 | $5.46M 10-K · filed 2019-11-25 |
| 2019-05-31 | $134.38K 10-Q · filed 2020-07-13 | |
| 2019-02-28 | -$692.17K 10-Q · filed 2020-07-13 | |
| 2018-11-30 | -$475.16K 10-Q · filed 2020-07-13 | |
| 2018-08-31 | -$134.97K 10-K · filed 2020-11-04 | |
| 2018-05-31 | -$91.34K 10-Q · filed 2019-07-15 | |
| 2018-02-28 | $215.18K 10-Q · filed 2019-07-15 | $385.29K 10-Q · filed 2018-04-16 |
| 2017-11-30 | $294.01K 10-Q · filed 2019-07-15 | |
| 2017-08-31 | $544.84K 10-K/A · filed 2019-12-18 | |
| 2017-05-31 | -$113.94K 10-Q · filed 2017-07-21 | |
| 2017-02-28 | -$19.47K 10-Q · filed 2017-04-14 | |
| 2016-11-30 | -$6.46K 10-Q · filed 2017-01-10 | |
| 2016-08-31 | -$13.80K 10-K · filed 2018-11-29 | |
| 2016-05-31 | -$9.47K 10-Q · filed 2016-07-05 | |
| 2016-02-29 | -$4.42K 10-Q · filed 2016-04-01 | |
| 2015-11-30 | $671.00 10-Q · filed 2016-01-14 | |
| 2015-08-31 | $15.89K 10-K · filed 2017-11-29 | $15.29K 10-K · filed 2015-12-11 |
| 2015-05-31 | $12.58K 10-Q · filed 2015-07-15 | |
| 2015-02-28 | $6.58K 10-Q · filed 2015-04-14 | |
| 2014-08-31 | $14.73K 10-K · filed 2016-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |